Drugs for Leukemia, Lymphoma and Myeloma

The information is about a portion of the more current, directed medication medicines for blood tumour that are beginning to be utilized or have been as of late affirmed for use in individuals with Blood Cancer. The list includes generic and brand names. This page likewise records basic medication mixes utilized as a part of leukemia. The individual medications in the mixes are FDA-endorsed. List of cancer medicine approved by the nourishment and drugs Administration for non-Hodgkin lymphoma. Chemotherapy is the utilization of medicines to crush or control malignancy cells. These medications can be taken by mouth or given in a vein or a muscle. They enter the circulation system and achieve all regions of the body

Leukemia Drugs:

  • Arranon (Nelarabine)
  • Asparaginase Erwinia chrysanthemi
  • Hyper-CVAD

Lymphoma Drugs:

  • Doxorubicin
  • Bleomycin
  • Vinblastine

Myeloma Drugs:

  • Melphalan
  • Vincristine (Oncovin)
  • Cyclophosphamide (Cytoxan)

 

  • Arranon (Nelarabine)
  • Asparaginase Erwinia chrysanthemi
  • Doxorubicin, Bleomycin, Vinblastine,Dacarbazine
  • Melphalan Vincristine (Oncovin),Cyclophosphamide (Cytoxan), Etoposide (VP-16)

Related Conference of Drugs for Leukemia, Lymphoma and Myeloma

April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
May 26-27, 2025

15th World Congress on Breast Cancer

Rome, Italy
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 13-14, 2025

8th International Conference on Anti-Cancer Drugs & Therapies

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain

Drugs for Leukemia, Lymphoma and Myeloma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in